Navigation Links
Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion
Date:7/29/2008

New Jersey Health Care Quality Institute Announces Results of Milken

Institute Study

Future Costs Can Be Avoided with Proper Treatment and Prevention

Initiatives

NEW BRUNSWICK, N.J., July 29 /PRNewswire/ -- In a groundbreaking study released by the Milken Institute, the annual economic impact on New Jersey's economy of the most common chronic diseases is calculated to be $39 billion. In the U.S. as a whole, the cost is a staggering $1 trillion, which could balloon to nearly $6 trillion by the middle of the century.

Yet the news is not entirely grim because much of the future cost is avoidable.

"An Unhealthy America: The Economic Burden of Chronic Disease" brings to light for the first time what is often overlooked in the discussion of the impact of chronic disease-the economic loss associated with preventable illness and the cost to the nation's Gross Domestic Product (GDP) and American businesses in lost growth.

The results of the study were released at a press briefing sponsored by the New Jersey Health Care Quality Institute at the Heldrich Hotel in New Brunswick.

"This is a healthcare no-brainer," said David L. Knowlton, President & CEO of the New Jersey Health Care Quality Institute. "We can continue to ignore the consequences of not properly investing in treatment and prevention alternatives or we can make those investments and reap billions in savings."

"The data presented by the Milken Institute today highlights the true cost burden of our failure to address chronic disease," added Professor Carl Van Horn, Ph.D., director of the Heldrich Center. "We must reduce the rate of chronic disease to avoid potentially devastating economic damage to our state and nation."

According to the study, seven chronic diseases-cancer, diabetes, hypertension, stroke, heart disease, pulmonary conditions and mental illness- have a total impact on New J
'/>"/>

SOURCE New Jersey Health Care Quality Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
2. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
3. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
4. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
5. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
6. Annual flu shot cuts need for doctors visits, hospitalization among children
7. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
8. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
9. Chem Rx to Present at Bear Stearns 20th Annual Healthcare Conference
10. BioMarin to Present at the Bear Stearns 20th Annual Healthcare Conference
11. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswire/ ...essional cycling team dedicated to ethical sportin...ampions, announced today that it will become Team ...s Optical as a new sponsor of the team. Transition...daptive eyewear, offering the most advanced photoc...
(Date:11/27/2009)... XenaCare Holdings has announced that... Foundation, one of the largest nonprofit organiza...ealth education. , Delray...oldings, Inc. (OTCBB: XCHO), a company specializin...umer healthcare products, has announced today that...
(Date:11/27/2009)...s to bring unprecedented medical, economic burdens...althDay News) -- The number of people with diabete...the next 25 years, a new study predicts. , That...on people with the disease, up from 23.7 million t... people with diabetes will triple, the study also ...
(Date:11/27/2009)... Voyant Health™ announced today... licensed its TraumaCad Enterprise orthopedic temp...solution. , (PRWEB) Novem...ay that Spectrum Health (Grand Rapids, Michigan) h...mplating solution and its TraumaCad Extend workflo...
(Date:11/27/2009)... Specialist manufacturers who use med... saving millions of dollars by bringing in technol...ncreasing numbers of pro-active medical manufactur...e concept stage of their projects, ensuring that p... processes or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...r and sanitation severely limited in Lebanon due t...ncies have stepped up preparations for a coordinat...ess to health care for injured and patients with c...h attacks on July 12. WHO said it is assistin...
...t after memory begins to decline, executive functi...e progression from mild cognitive// impairment, a ...disease. Ron Petersen, M.D., Ph.D., Mayo Cli... "If someone with mild cognitive impairment start...
...ases the risk of hospitalization and death from he... absence of established// risk factors, says a stu... Association. An assistant professor of pre... in early life with hospitalization and subsequent...
... going by the current trends tobacco will probably...e almost 10 times the toll// it took in the 20th c...r of the American Cancer Society said, "In all of ...ncer, 1 in 5 death due to cancer is due to tobacco...
...hout Africa could help to avert about 5,7-million ... that was published in Public Library of Science M... 300 000 deaths and about two million new infectio... circumcision reduces male vulnerability to HIV in...
...ve birth to triplets through IVF procedure three y...ut any infertility treatments. She gave birth to t... because they're healthy and so am I," Magdaleno s...'m happy but, I don't know. I don't know how to ex...
Other Medicine News:Health News:Decline in Concentration, Decision-Making and Problem-Solving 2Health News:Tobacco Epidemic On The Rise 2Health News:Circumcision to Avert HIV Infection 2
(Date:11/27/2009)...Minn, Nov. 27 ACUO TECHNOLOGIES, d...ment software, data migration tools and services, ...nt and Trademark Office has approved a patent appl...a Computer Network." Acuo Technologies is pleased ...ctual property. In general, the granted patent app...
(Date:11/26/2009)...BURG, South Africa, Nov. 26 The 20...e Year Award in the Generic Pharmaceutical Market ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh...ar Award, the following criteria were used to benc...titors: growth strategy and implementation, degree...
(Date:11/25/2009)...Fla., Nov. 25 American...he Company") is pleased to announce that they have...ment office in Shanghai, China. ,, ASR has been...sential gateway for the development and production...for children and adults to be distributed and sold...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 1Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 2Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 1Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 1American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 3
...entative medicine doctors say they are outraged,ov...rescribing,human growth hormone to treat a hormone...BEACH, Fla., April 27, 2007 /PRNewswire/ -- The ad...enter of a recent New,York Times article about the...dicine (<a target="_blank" href=,"http://worldheal...
...: 0in 0in 0pt; TEXT-ALIGN: left; tab-stops: 0in",a...ab-stops: list .5in; mso-list: l1 level1 lfo2">, <...othic MT,; mso-bidi-font-weight: bold">,Independen... adding,Diovan to conventional therapy , , , ,<...in; mso-list: l1 level1 lfo2">, <span style=,"FONT...
Other Medicine Technology:Doctors Outraged Over Growth Hormone Controversy 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12
Blue Line® Intubation Stylet 7.5 mm 10 mm
Lighted Pediatric Stylet - Non-Sterile
Surch-Lite™ Flexible Light - 15" Non-Sterile
Peripheral Nerve Stimulator Electrodes
Medicine Products: